Cancer Hospital, CAMS

The Cancer Hospital of the Chinese Academy of Medical Sciences (CAMS), founded in 1958 and designated the National Cancer Center of China, is the country's first and apex specialty cancer institution — the authoritative national body for cancer policy, clinical research, and guideline development.

With approximately 1,500 inpatient beds across its Beijing main campus and Langfang branch, the hospital serves over 1 million outpatients and 76,000 inpatients annually, and has been commissioned by the National Health Commission to formulate and revise 33 tumor-specific diagnosis and treatment guidelines that set the clinical standard followed by every cancer hospital in China.

In January 2026, the hospital established China's first large-scale pan-cancer real-world genomic database, reinforcing its role as the national clearinghouse for cancer research and intelligence. The center operates one of China's first proton therapy facilities alongside an MRI-guided linear accelerator (MR-Linac) for adaptive radiation therapy, placing it at the forefront of precision oncology in Asia.